210 related articles for article (PubMed ID: 37784105)
81. ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis.
Yang M; Chen Y; Huang X; Shen F; Meng Y
Lung; 2023 Aug; 201(4):425-441. PubMed ID: 37490064
[TBL] [Abstract][Full Text] [Related]
82. Volumetric capnography in infants with bronchopulmonary dysplasia.
Fouzas S; Häcki C; Latzin P; Proietti E; Schulzke S; Frey U; Delgado-Eckert E
J Pediatr; 2014 Feb; 164(2):283-8.e1-3. PubMed ID: 24161220
[TBL] [Abstract][Full Text] [Related]
83. Diaphragmatic Thickness and Excursion in Preterm Infants With Bronchopulmonary Dysplasia Compared With Term or Near Term Infants: A Prospective Observational Study.
Yeung T; Mohsen N; Ghanem M; Ibrahim J; Shah J; Kajal D; Shah PS; Mohamed A
Chest; 2023 Feb; 163(2):324-331. PubMed ID: 35963296
[TBL] [Abstract][Full Text] [Related]
84. The association between clinical and biochemical characteristics of late-onset sepsis and bronchopulmonary dysplasia in preterm infants.
Ebrahimi ME; Romijn M; Vliegenthart RJS; Visser DH; van Kaam AH; Onland W
Eur J Pediatr; 2021 Jul; 180(7):2147-2154. PubMed ID: 33629121
[TBL] [Abstract][Full Text] [Related]
85. Gene Expression Signatures Point to a Male Sex-Specific Lung Mesenchymal Cell PDGF Receptor Signaling Defect in Infants Developing Bronchopulmonary Dysplasia.
Fulton CT; Cui TX; Goldsmith AM; Bermick J; Popova AP
Sci Rep; 2018 Nov; 8(1):17070. PubMed ID: 30459472
[TBL] [Abstract][Full Text] [Related]
86. [Changes and significance of type 2 innate lymphoid cells and their related factors in bronchopulmonary dysplasia].
Wang QW; Zhu Y; Wang QX; Lu HY
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Feb; 25(2):179-185. PubMed ID: 36854695
[TBL] [Abstract][Full Text] [Related]
87. Mitochondrial DNA mutations in extremely preterm infants with bronchopulmonary dysplasia.
Jeong J; Lee Y; Han J; Kang E; Kim D; Kim KS; Kim EA; Lee BS; Jung E
Gene; 2024 Jun; 910():148337. PubMed ID: 38432533
[TBL] [Abstract][Full Text] [Related]
88. Predictive values of plasma KL-6 in bronchopulmonary dysplasia in preterm infants.
Dilli D; Özyazici A; Dursun A; Beken S
Turk J Med Sci; 2017 Apr; 47(2):621-626. PubMed ID: 28425256
[TBL] [Abstract][Full Text] [Related]
89. Tracheal aspirate transcriptomic and miRNA signatures of extreme premature birth with bronchopulmonary dysplasia.
Oji-Mmuo CN; Siddaiah R; Montes DT; Pham MA; Spear D; Donnelly A; Fuentes N; Imamura-Kawasawa Y; Howrylak JA; Thomas NJ; Silveyra P
J Perinatol; 2021 Mar; 41(3):551-561. PubMed ID: 33177681
[TBL] [Abstract][Full Text] [Related]
90. Effect of bronchopulmonary dysplasia on early intellectual development in preterm infants.
Lin F; Dong H; Song Y; Zhang T; Qi J; Xiao X; Cai Y
Pediatr Int; 2017 Jun; 59(6):691-697. PubMed ID: 28177185
[TBL] [Abstract][Full Text] [Related]
91. [Changes of serum interleukin-33 in preterm infants with bronchopulmonary dysplasia].
Chen JL; Zhang CL
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):716-720. PubMed ID: 32669167
[TBL] [Abstract][Full Text] [Related]
92. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Munshi UK; Niu JO; Siddiq MM; Parton LA
Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566
[TBL] [Abstract][Full Text] [Related]
93. Development of a peripheral blood transcriptomic gene signature to predict bronchopulmonary dysplasia.
Moreira A; Tovar M; Smith AM; Lee GC; Meunier JA; Cheema Z; Moreira A; Winter C; Mustafa SB; Seidner S; Findley T; Garcia JGN; Thébaud B; Kwinta P; Ahuja SK
Am J Physiol Lung Cell Mol Physiol; 2023 Jan; 324(1):L76-L87. PubMed ID: 36472344
[TBL] [Abstract][Full Text] [Related]
94. Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis.
Lan J; Chen X; Xu F; Tao F; Liu L; Cheng R; Li N; Pan Y
Mikrochim Acta; 2023 Nov; 190(12):491. PubMed ID: 38030848
[TBL] [Abstract][Full Text] [Related]
95. Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants.
Inoue H; Ohga S; Kusuda T; Kitajima J; Kinjo T; Ochiai M; Takahata Y; Honjo S; Hara T
Early Hum Dev; 2013 Jun; 89(6):425-9. PubMed ID: 23332549
[TBL] [Abstract][Full Text] [Related]
96. Comparison of two novel diagnostic criteria for bronchopulmonary dysplasia in predicting adverse outcomes of preterm infants: a retrospective cohort study.
Wang X; Lu YK; Wu YY; Liu DP; Guo J; Li MC; Wang Y; Li R; Zhang XY; Kang WQ
BMC Pulm Med; 2023 Aug; 23(1):308. PubMed ID: 37612680
[TBL] [Abstract][Full Text] [Related]
97. Changing expression profiles of mRNA, lncRNA, circRNA, and miRNA in lung tissue reveal the pathophysiological of bronchopulmonary dysplasia (BPD) in mouse model.
Wang J; Yin J; Wang X; Liu H; Hu Y; Yan X; Zhuang B; Yu Z; Han S
J Cell Biochem; 2019 Jun; 120(6):9369-9380. PubMed ID: 30802330
[TBL] [Abstract][Full Text] [Related]
98. Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study.
Onland W; Debray TP; Laughon MM; Miedema M; Cools F; Askie LM; Asselin JM; Calvert SA; Courtney SE; Dani C; Durand DJ; Marlow N; Peacock JL; Pillow JJ; Soll RF; Thome UH; Truffert P; Schreiber MD; Van Reempts P; Vendettuoli V; Vento G; van Kaam AH; Moons KG; Offringa M
BMC Pediatr; 2013 Dec; 13():207. PubMed ID: 24345305
[TBL] [Abstract][Full Text] [Related]
99. Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis.
Stoecklin B; Simpson SJ; Pillow JJ
Paediatr Respir Rev; 2019 Nov; 32():91-97. PubMed ID: 30745153
[TBL] [Abstract][Full Text] [Related]
100. Analysis of the value of echocardiographic parameters in the early diagnosis of preterm infants with bronchopulmonary dysplasia.
Mao L; Wu Y; Shu X; Li S; Huang L
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7988-7996. PubMed ID: 37750627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
